The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid
- PMID: 35336928
- PMCID: PMC8955406
- DOI: 10.3390/v14030521
The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid
Abstract
Negative-stranded RNA viruses (NSVs) are important human pathogens, including emerging and reemerging viruses that cause respiratory, hemorrhagic and other severe illnesses. Vaccine design traditionally relies on the viral surface glycoproteins. However, surface glycoproteins rarely elicit effective long-term immunity due to high variability. Therefore, an alternative approach is to include conserved structural proteins such as nucleoprotein (NP). NP is engaged in myriad processes in the viral life cycle: coating and protection of viral RNA, regulation of transcription/replication processes and induction of immunosuppression of the host. A broad heterosubtypic T-cellular protection was ascribed very early to this protein. In contrast, the understanding of the humoral immunity to NP is very limited in spite of the high titer of non-neutralizing NP-specific antibodies raised upon natural infection or immunization. In this review, the data with important implications for the understanding of the role of NP in the immune response to human NSVs are revisited. Major implications of the elicited T-cell immune responses to NP are evaluated, and the possible multiple mechanisms of the neglected humoral response to NP are discussed. The intention of this review is to remind that NP is a very promising target for the development of future vaccines.
Keywords: B-cell immune response; T-cell immune response; negative-stranded RNA viruses; nucleoprotein; vaccines.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.J Immunol. 2008 Sep 15;181(6):4168-76. doi: 10.4049/jimmunol.181.6.4168. J Immunol. 2008. PMID: 18768874 Free PMC article.
-
Broadly Protective CD8+ T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine.J Virol. 2021 May 24;95(12):e00507-21. doi: 10.1128/JVI.00507-21. Print 2021 May 24. J Virol. 2021. PMID: 33827939 Free PMC article.
-
Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.J Virol. 2013 May;87(10):5985-93. doi: 10.1128/JVI.00120-13. Epub 2013 Mar 20. J Virol. 2013. PMID: 23514880 Free PMC article.
-
Progress on adenovirus-vectored universal influenza vaccines.Hum Vaccin Immunother. 2015;11(5):1209-22. doi: 10.1080/21645515.2015.1016674. Hum Vaccin Immunother. 2015. PMID: 25876176 Free PMC article. Review.
-
Development of universal influenza vaccines based on influenza virus M and NP genes.Infection. 2014 Apr;42(2):251-62. doi: 10.1007/s15010-013-0546-4. Epub 2013 Nov 1. Infection. 2014. PMID: 24178189 Review.
Cited by
-
Negative and ambisense RNA virus ribonucleocapsids: more than protective armor.Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0008223. doi: 10.1128/mmbr.00082-23. Epub 2023 Sep 26. Microbiol Mol Biol Rev. 2023. PMID: 37750733 Free PMC article. Review.
-
Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus.Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2437-2450. doi: 10.1007/s00253-023-12433-3. Epub 2023 Feb 23. Appl Microbiol Biotechnol. 2023. PMID: 36820898 Free PMC article.
-
Cellular immunity to nucleoproteins (NP) of Crimean-Congo hemorrhagic fever virus (CCHFV) and Hazara Virus (HAZV).Med Microbiol Immunol. 2024 Sep 25;213(1):20. doi: 10.1007/s00430-024-00802-2. Med Microbiol Immunol. 2024. PMID: 39320473
-
Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus.Nat Commun. 2024 Feb 26;15(1):1722. doi: 10.1038/s41467-024-46110-4. Nat Commun. 2024. PMID: 38409240 Free PMC article.
-
Molecular Population Genetics of Aspen Mosaic-Associated Virus in Finland and Sweden.Viruses. 2023 Aug 1;15(8):1678. doi: 10.3390/v15081678. Viruses. 2023. PMID: 37632020 Free PMC article.
References
-
- Hartman A.L., Towner J.S., Nichol S.T. After Marburg, Ebola. Lancet. 1977;1:581–582. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous